CYTOVENE

This brand name is authorized in Canada, United States

Active ingredients

The drug CYTOVENE contains one active pharmaceutical ingredient (API):

1 Ganciclovir UNII 02L083W284 - GANCICLOVIR SODIUM

Ganciclovir, 9-(1,3-dihydroxy-2-propoxymethyl)guanine or DHPG, is a broadspectrum virustatic agent which inhibits the replication of viruses, including viruses of the herpes group, both in vivo and in vitro: herpes simplex types 1 and 2 (HSV), cytomegalovirus (CMV), Epstein-Barr virus (EBV), herpes zoster (HZV). Read about Ganciclovir

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
CYTOVENE-IV Solution for injection	FDA, National Drug Code (US)	MPI, US: SPL/PLR

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
J05AB06	Ganciclovir	J Antiinfectives for systemic use → J05 Antivirals for systemic use → J05A Direct acting antivirals → J05AB Nucleosides and nucleotides excl. reverse transcriptase inhibitors
Discover more medicines within J05AB06

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: CA	Health Products and Food Branch	Identifier(s): 02162695
Country: US	FDA, National Drug Code	Identifier(s): 61269-450